FMI Learn details of the Women’s Health Diagnostic Tes | Page 6

Women’s Health Diagnostic Testing Market
Depending on geographic region, the women’s health diagnostic testing market is segmented into seven
key regions: North America, Latin America, Eastern Europe, Western Europe, Asia Pacific, Japan, and
Middle East & Africa.
North America is the largest regional market owing to high patient awareness levels regarding various
diagnostic testing procedures for women, increasing healthcare expenditure, reimbursement options and
relatively larger number of R&D exercises pertaining new product launch and marketing etc. these factors
contribute for significant revenue generation for diagnostic testing devices from the region.
Request For TOC@ http://www.futuremarketinsights.com/toc/rep-gb-3204
Asia Pacific is expected to grow at the fastest CAGR because of increasing prevalence of breast cancer in
women. Also increase in geriatric population leads to more number of cases with osteoporosis is
expected to boost the revenue growth of women’s health diagnostic testing market throughout the
forecast period.
Women’s Health diagnostic testing Market: Key Players
Some players of women’s health diagnostic testing market includes GE Healthcare, Becton, Dickinson
and Company, Koninklijke Philips N.V., PerkinElmer Inc., Abbott Laboratories, Quest Diagnostics Inc.,
Hologic, Inc., Siemens Healthcare GmbH, F. Hoffmann-La Roche AG whereas some regional players also
have a significant presence in Women’s Health diagnostic testing market.
©2015 Future Market Insights, All Rights Reserved
6